Elite members get real-time data, technical charting, alerts, and no ads - starting at $24.96/mo.
Try Elite for Free
Index
-
Market Cap
4.01M
Enterprise Value
136.85M
Income
-33.04M
Sales
47.13M
Book/sh
-111.67
Cash/sh
8.03
Employees
287
IPO
Oct 21, 1992
P/E
-
Forward P/E
-
PEG
-
P/S
0.09
P/B
-
P/C
0.78
P/FCF
-
EV/EBITDA
-
EV/Sales
2.90
Quick Ratio
0.12
Current Ratio
0.25
Debt/Eq
-
LT Debt/Eq
-
Option/Short
No / Yes
EPS (ttm)
-52.93
EPS next Y
-
EPS next Q
-
EPS this Y
-
EPS next Y
-
EPS next 5Y
-
EPS past 3/5Y
30.77% -5.58%
Sales past 3/5Y
-11.12% -15.62%
EPS Y/Y TTM
39.65%
Sales Y/Y TTM
-13.28%
EPS Q/Q
52.53%
Sales Q/Q
43.08%
Earnings
-
EPS/Sales Surpr.
-311.83% -3.90%
Insider Own
3.57%
Insider Trans
0.00%
Inst Own
4.55%
Inst Trans
-1.19%
ROA
-35.91%
ROE
-
ROIC
-
Gross Margin
32.95%
Oper. Margin
-23.88%
Profit Margin
-70.10%
SMA20
-10.88%
SMA50
-18.61%
SMA200
-59.40%
Trades
Shs Outstand
0.64M
Shs Float
0.62M
52W High
52.50 -88.08%
52W Low
5.01 24.95%
Volatility
6.66% 12.59%
ATR (14)
0.78
RSI (14)
38.19
Beta
1.00
Rel Volume
0.00
Avg Volume
18.97K
Volume
0
Perf Week
-14.24%
Perf Month
-0.95%
Perf Quarter
-43.73%
Perf Half Y
-65.65%
Perf YTD
-73.62%
Perf Year
-79.13%
Perf 3Y
-90.38%
Perf 5Y
-97.97%
Perf 10Y
-99.40%
Prev Close
6.26
Price
6.26
Change %
0.00%
Consensus
Strong Buy
Avg. Price Target
$450.00
Implied Upside
+7,088.5%
Analysts3incl. previous ratings
Rating Distribution2 Buy · 1 Hold · 0 Sell
DateActionAnalystRating ChangePrice Target ChangeImplied Upside
Oct 23, 2015Downgrade
CCraig Hallum
Buy → Hold
Sep 03, 2015Initiated
RJF logoRRaymond James
Outperform
Jul 29, 2015Reiterated
RROTH Capital
Buy$22 → $20+219.5%
Jul 22, 2008Reiterated
RRoth Capital
Buy$7 → $6-4.2%
Mar 17, 2008Reiterated
RRoth Capital
Buy$10.50 → $7+11.8%
Dec 10, 2007Reiterated
RRoth Capital
Buy$11.50 → $10.50+67.7%
Oct 26, 2007Reiterated
RRoth Capital
Buy$13 → $11.50+83.7%
Trinity Biotech Plc engages in the development, manufacture, and marketing of medical diagnostic products for the clinical laboratory and point-of-care segments of the diagnostic market. It operates through the Americas and Rest of World-Ireland geographical segments. The company was founded by Ronan O'Caoimh and Denis R. Burger in June 1992 and is headquartered in Bray, Ireland.
PresidentMr. John Gillard
FounderMr. Ronan O'Caoimh A.C.A.
Interim Chief Financial OfficerPaul Murphy
Director of OperationsMs. Jacqueline O'Neill
Chief Technology OfficerDr. Gary Keating Ph.D.